SanBio Announces Publication of STEMTRA Phase 2 Interim Analysis for SB623 in Neurology

TOKYO & MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--The interim analysis from the SB623 Phase 2 clinical “STEMTRA" trial was published in the January 4, 2021 online issue of Neurology®.

Click to view original post